Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07156526 · ClinicalTrials.gov registry record · NA
Impact of Two Iron Formulations on Iron Biomarkers and Quality of Life
A NA study, sponsored by Qualia Life Sciences.
- Not yet
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT07156526 is a NA study that has not yet begun recruiting, run by Qualia Life Sciences. The registered enrollment target is 40 participants.
The verdict
NCT07156526, a NA study, has not yet begun recruiting, sponsored by Qualia Life Sciences.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
This randomized, double-blind parallel pilot study will evaluate the safety and efficacy of two Qualia Iron formulations versus placebo in approximately 40 healthy adults (aged 18+) over a 56-day period. Approximately 40 participants will be randomized to three study arms: Qualia Iron Version 1, 2, (n=15 each) or a Placebo (n=10). Each participant will take one or two capsules once daily in the morning, with or without food. The supplementation regimen is a 5 days on, 2 days off protocol, and goes for 56 days (8 weeks). The primary outcomes of this study are to assess between-group changes in iron status biomarkers. Secondary outcomes include within-group changes in iron status biomarkers, safety and tolerability as measured by a custom Safety and Tolerability survey, and RAND SF-36 quality of life scores.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Qualia Iron Version A
- DIETARY_SUPPLEMENT Qualia Iron Version B
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-09-10 |
| Est. Completion | 2025-11-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07156526
The ClinicalTrials.gov registry entry for NCT07156526 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Qualia Life Sciences, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT07156526 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07156526 about?
NCT07156526 is a clinical study titled "Impact of Two Iron Formulations on Iron Biomarkers and Quality of Life". This randomized, double-blind parallel pilot study will evaluate the safety and efficacy of two Qualia Iron formulations versus placebo in approximately 40 healthy adults (aged 18+) over a 56-day period. Approximately 40 participants will be randomized to three study arms: Qualia Iron Version 1, 2, ...
What is the current status of trial NCT07156526?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-09-10. Estimated completion is 2025-11-15.
What interventions are being tested in trial NCT07156526?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Qualia Iron Version A (DIETARY_SUPPLEMENT), Qualia Iron Version B (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07156526?
This trial is sponsored by Qualia Life Sciences, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.